Literature DB >> 17968536

Effect of divalent cations on the structure of the antibiotic daptomycin.

Steven W Ho1, David Jung, Jennifer R Calhoun, James D Lear, Mark Okon, Walter R P Scott, Robert E W Hancock, Suzana K Straus.   

Abstract

Daptomycin, a cyclic anionic lipopeptide antibiotic, whose three-dimensional structure was recently solved using solution state NMR (Ball et al. 2004; Jung et al. 2004; Rotondi and Gierasch 2005), requires calcium for function. To date, the exact nature of the interaction between divalent cations, such as Ca(2+) or Mg(2+), has not been fully characterized. It has, however, been suggested that addition of Ca(2+) to daptomycin in a 1:1 molar ratio induces aggregation. Moreover, it has been suggested that certain residues, e.g. Asp3 and Asp7, which are essential for activity (Grunewald et al. 2004; Kopp et al. 2006), may also be important for Ca(2+) binding (Jung et al. 2004). In this work, we have tried: (1) to further pinpoint how Ca(2+) affects daptomycin structure/oligomerization using analytical ultracentrifugation; and (2) to determine whether a specific calcium binding site exists, based on one-dimensional (13)C NMR spectra and molecular dynamics (MD) simulations. The centrifugation results indicated that daptomycin formed micelles of between 14 and 16 monomers in the presence of a 1:1 molar ratio of Ca(2+) and daptomycin. The (13)C NMR data indicated that addition of calcium had a significant effect on the Trp1 and Kyn13 residues, indicating that either calcium binds in this region or that these residues may be important for oligomerization. Finally, the molecular dynamics simulation results indicated that the conformational change of daptomycin upon calcium binding might not be as significant as originally proposed. Similar studies on the divalent cation Mg(2+) are also presented. The implication of these results for the biological function of daptomycin is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968536     DOI: 10.1007/s00249-007-0227-2

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  36 in total

Review 1.  The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy.

Authors:  B Bechinger
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145.

Authors:  Florian Kopp; Jan Grünewald; Christoph Mahlert; Mohamed A Marahiel
Journal:  Biochemistry       Date:  2006-09-05       Impact factor: 3.162

Review 3.  Calcium binding proteins. Elucidating the contributions to calcium affinity from an analysis of species variants and peptide fragments.

Authors:  B J Marsden; G S Shaw; B D Sykes
Journal:  Biochem Cell Biol       Date:  1990-03       Impact factor: 3.626

4.  Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.

Authors:  Jennifer M Streit; Judith N Steenbergen; Grace M Thorne; Jeffrey Alder; Ronald N Jones
Journal:  J Antimicrob Chemother       Date:  2005-02-18       Impact factor: 5.790

5.  1,2-Dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG) monolayers: influence of temperature, pH, ionic strength and binding of alkaline earth cations.

Authors:  Patrick Garidel; Alfred Blume
Journal:  Chem Phys Lipids       Date:  2005-09-06       Impact factor: 3.329

6.  The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis.

Authors:  M Boaretti; P Canepari; M M Lleò; G Satta
Journal:  J Antimicrob Chemother       Date:  1993-02       Impact factor: 5.790

7.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

8.  Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes.

Authors:  J H Lakey; M Ptak
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

9.  Calcium binding to mixed phosphatidylglycerol-phosphatidylcholine bilayers as studied by deuterium nuclear magnetic resonance.

Authors:  P M Macdonald; J Seelig
Journal:  Biochemistry       Date:  1987-03-10       Impact factor: 3.162

10.  NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin.

Authors:  Lee-Jon Ball; Catherine M Goult; James A Donarski; Jason Micklefield; Vasudevan Ramesh
Journal:  Org Biomol Chem       Date:  2004-06-15       Impact factor: 3.876

View more
  35 in total

1.  Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms.

Authors:  Vanessa M D'Costa; Tariq A Mukhtar; Tejal Patel; Kalinka Koteva; Nicholas Waglechner; Donald W Hughes; Gerard D Wright; Gianfranco De Pascale
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 2.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

3.  Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.

Authors:  T Böttiger; T Schneider; B Martínez; H-G Sahl; I Wiedemann
Journal:  Appl Environ Microbiol       Date:  2009-05-08       Impact factor: 4.792

4.  Molecular State of the Membrane-Active Antibiotic Daptomycin.

Authors:  Ming-Tao Lee; Wei-Chin Hung; Meng-Hsuan Hsieh; Hsiung Chen; Yu-Yung Chang; Huey W Huang
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

5.  Daptomycin-Phosphatidylglycerol Domains in Lipid Membranes.

Authors:  Mark A Kreutzberger; Antje Pokorny; Paulo F Almeida
Journal:  Langmuir       Date:  2017-11-13       Impact factor: 3.882

Review 6.  Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.

Authors:  Lars Robbel; Mohamed A Marahiel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 7.  Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.

Authors:  Antonio D'Avolio; Debora Pensi; Lorena Baietto; Giovanni Pacini; Giovanni Di Perri; Francesco Giuseppe De Rosa
Journal:  Drugs       Date:  2016-08       Impact factor: 9.546

8.  Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

Authors:  Dominique Dugourd; Haiyan Yang; Melissa Elliott; Raymond Siu; Jacob J Clement; Suzana K Straus; Robert E W Hancock; Evelina Rubinchik
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

Review 9.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.

Authors:  Kien T Nguyen; Xiaowei He; Dylan C Alexander; Chen Li; Jian-Qiao Gu; Carmela Mascio; Andrew Van Praagh; Larry Mortin; Min Chu; Jared A Silverman; Paul Brian; Richard H Baltz
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.